n-methyl-3,4-methylenedioxyamphetamine has been researched along with Degenerative Diseases, Central Nervous System in 8 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, X | 1 |
| Li, S | 1 |
| Li, J | 1 |
| Qi, R | 1 |
| Zhong, L | 1 |
| Yu, H | 1 |
| Costa, G | 1 |
| Porceddu, PF | 1 |
| Serra, M | 1 |
| Casu, MA | 1 |
| Schiano, V | 1 |
| Napolitano, F | 1 |
| Pinna, A | 1 |
| Usiello, A | 1 |
| Morelli, M | 1 |
| Bissette, G | 1 |
| Green, AR | 4 |
| Mechan, AO | 1 |
| Elliott, JM | 1 |
| O'Shea, E | 4 |
| Colado, MI | 3 |
| Cadet, JL | 1 |
| Brannock, C | 1 |
| Granados, R | 1 |
| Esteban, B | 2 |
| MartÃn, AB | 1 |
| Easton, N | 1 |
| Fry, JR | 1 |
| Marsden, CA | 1 |
3 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Does Alzheimer's disease result from attempts at repair or protection after transient stress?
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Craniocerebral Tr | 2009 |
The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Topics: Animals; Behavior, Animal; Body Temperature; Brain; Dopamine; Free Radicals; Hallucinogens; Humans; | 2003 |
Free radicals and the pathobiology of brain dopamine systems.
Topics: Animals; Brain; Dopamine; Free Radicals; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyampheta | 1998 |
5 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
MDMA targets miR-124/MEKK3 via MALAT1 to promote Parkinson's disease progression.
Topics: Animals; Apoptosis; Cell Line, Tumor; Disease Progression; Dopaminergic Neurons; Humans; MicroRNAs; | 2023 |
Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age.
Topics: Age Factors; Animals; Dopaminergic Neurons; Female; Gene Deletion; GTP-Binding Proteins; Hallucinoge | 2019 |
Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.
Topics: Animals; Body Temperature; Brain; Dopamine; Free Radicals; Haloperidol; Levodopa; Male; N-Methyl-3,4 | 1999 |
Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ("ecstasy")-induced neurodegeneration in rat brain.
Topics: Animals; Body Temperature; Chlormethiazole; Male; Methylamines; N-Methyl-3,4-methylenedioxyamphetami | 2001 |
Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia.
Topics: Animals; Brain; Brain Chemistry; Buthionine Sulfoximine; Drug Therapy, Combination; Fever; Glutathio | 2002 |